Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 19 July, 2016

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 6589E
GlaxoSmithKline PLC
19 July 2016
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr M M Slaoui

b)

Position/status

Chairman, Global Vaccines

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

 

ISIN: US37733W1053

b)

Nature of the transaction

Increase in notional interest in ADSs following the re-investment of dividends paid to shareholders on 14 July 2016 on ADSs held in the Company's 2009 Performance Share Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$43.87

1,450.310

$43.87

1,609.277

$43.87

1,842.849

 

 

d)

Aggregated information

 

Aggregated volume Price

 

 

 

 

4,902.436 ADSs

$43.87 

e)

Date of the transaction

2016-07-14

f)

Place of the transaction

 

n/a

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHQKLFFQDFEBBL

a d v e r t i s e m e n t